PrEP Today: An HIV Prevention Revolution

11/13/23 • 26 min

In this episode, global PrEP experts and advocates discuss how current PrEP regimens represent a revolutionary step forward in enabling many individuals to avoid HIV acquisition, including:

How PrEP has empowered people to take control of their sexual lives, revolutionized people’s sexual experiences, and, for some, improved their experiences with healthcare in general
The extraordinary progress that has been made in New South Wales and specifically in inner Sydney toward HIV transmission elimination and the role of PrEP in the prevention of new HIV infections
The importance of having PrEP options, including on-demand options and long-acting formulations, available to different populations who could benefit to see progress toward HIV transmission elimination globally

Faculty:

Jessica L. Adams, PharmD, AAHIVE
Scientific Director, Infectious Diseases
Clinical Care Options
New York, United States

Linda-Gail Bekker, MBChB, DCH, DTM&H, FCP(SA), PhD
Professor and Director
The Desmond Tutu HIV Centre
University of Cape Town
South Africa
Chief Executive Officer
The Desmond Tutu Health Foundation
Cape Town, South Africa

Kenyon R. Farrow
PrEP Advocate
Vice President of Policy
Point Source Youth
Contributing Editor
TheBody.com
Ohio, United States

Beatriz Grinsztejn, MD, PhD
Director
STI/AIDS Clinical Research Laboratory
Instituto Nacional de Infectologia Evandro Chagas-Fiocruz
Rio de Janeiro, Brazil

Andrew Grulich, MBBS, PhD
Scientia Professor
Head, HIV Epidemiology and Prevention Program
The Kirby Institute
University of New South Wales, Sydney
New South Wales, Australia

Jean-Michel Molina, MD, PhD
Professor of Infectious Diseases
University of Paris Cité
Head of the Department of Infectious Diseases
Hospital Saint-Louis and Lariboisière
Paris, France

Brittany Williams, PhD
PrEP Advocate
Assistant Professor of Higher Education and Student Affairs Administration
Department of Education
University of Vermont
Vermont, United States

Link to full program:
https://bit.ly/3FbPBey

In this episode, global PrEP experts and advocates discuss how current PrEP regimens represent a revolutionary step forward in enabling many individuals to avoid HIV acquisition, including:

How PrEP has empowered people to take control of their sexual lives, revolutionized people’s sexual experiences, and, for some, improved their experiences with healthcare in general
The extraordinary progress that has been made in New South Wales and specifically in inner Sydney toward HIV transmission elimination and the role of PrEP in the prevention of new HIV infections
The importance of having PrEP options, including on-demand options and long-acting formulations, available to different populations who could benefit to see progress toward HIV transmission elimination globally

Faculty:

Jessica L. Adams, PharmD, AAHIVE
Scientific Director, Infectious Diseases
Clinical Care Options
New York, United States

Kenyon R. Farrow
PrEP Advocate
Vice President of Policy
Point Source Youth
Contributing Editor
TheBody.com
Ohio, United States

Beatriz Grinsztejn, MD, PhD
Director
STI/AIDS Clinical Research Laboratory
Instituto Nacional de Infectologia Evandro Chagas-Fiocruz
Rio de Janeiro, Brazil

Andrew Grulich, MBBS, PhD
Scientia Professor
Head, HIV Epidemiology and Prevention Program
The Kirby Institute
University of New South Wales, Sydney
New South Wales, Australia

Jean-Michel Molina, MD, PhD
Professor of Infectious Diseases
University of Paris Cité
Head of the Department of Infectious Diseases
Hospital Saint-Louis and Lariboisière
Paris, France

Brittany Williams, PhD
PrEP Advocate
Assistant Professor of Higher Education and Student Affairs Administration
Department of Education
University of Vermont
Vermont, United States

Link to full program:
https://bit.ly/3FbPBey

Previous Episode

Unlocking the Promise of PrEP and the Future of PrEP

In this episode, global PrEP experts and advocates discuss barriers that have prevented the full potential of today’s PrEP regimens from being delivered, how those barriers might be overcome, and how the next generation of PrEP modalities may address unmet needs, including:

How access and implementation of PrEP have limited its benefit and led to disparities in uptake among racial and ethnic groups in the United States and among key populations globally
The challenges of adherence to PrEP for healthy individuals who are required to consistently take medication and engage with the healthcare system when they aren’t sick
The potential for longer-acting PrEP modalities and a greater number of PrEP options for individuals in the future to expand PrEP uptake and adherence with equitable global access

Faculty:

Jessica L. Adams, PharmD, AAHIVE
Scientific Director, Infectious Diseases
Clinical Care Options
New York, United States

Kenyon R. Farrow
PrEP Advocate
Vice President of Policy
Point Source Youth
Contributing Editor
TheBody.com
Ohio, United States

Beatriz Grinsztejn, MD, PhD
Director
STI/AIDS Clinical Research Laboratory
Instituto Nacional de Infectologia Evandro Chagas-Fiocruz
Rio de Janeiro, Brazil

Brittany Williams, PhD
PrEP Advocate
Assistant Professor of Higher Education and Student Affairs Administration
Department of Education
University of Vermont
Vermont, United States

Link to full program:
https://bit.ly/3FbPBey

Next Episode

Where We’re Going: The Next Wave of Antiretroviral Innovations

In this second of 3 episodes, global HIV experts and advocates discuss how HIV care can better meet the diverse needs of people living with HIV as new treatment strategies emerge and continue to evolve, including:

How the emergence of long-acting injectable HIV treatment has been a game-changer for many people living with HIV
Emerging strategies that are expanding the application of long-acting ART to address unmet treatment needs
Potential for future innovations in ART that are hoped will further address unmet needs and preferences of people living with HIV

Faculty:

Ann Avery, MD
Professor of Medicine
Case Western Reserve University
Division of Infectious Diseases
MetroHealth Medical Center
Cleveland, Ohio

Jennifer Blanchette, PhD
Independent Contractor
Clinical Care Options
Colorado, United States

Isolde Butler, MD, MPH
Chief Medical Officer
CrescentCare
New Orleans, Louisiana

Monica Gandhi, MD, MPH
Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
Director, Center for AIDS Research (CFAR)
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco (UCSF)
San Francisco, California

Marissa Gonzalez
Chair
Community Advisory Board
The Well Project

Angelina Namiba
Founder Member
4M Network of Mentor Mothers
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD
Professor of Infection and Inequities
Faculty of Medicine and Dentistry
Queen Mary University of London
Blizard Institute
Barts Health NHS Trust
London, United Kingdom

Link to full program:
https://bit.ly/3QFwv7n

Links to programs discussed in the episode:
www.4mmm.org